Tolerability, Safety, and Efficacy of Efzofitimod in Patients With Pulmonary Sarcoidosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efzofitimod for the treatment of pulmonary sarcoidosis
Chest 2022 Nov 07;[EPub Ahead of Print], DA Culver, S Aryal, J Barney, CCW Hsia, WE James, LA Maier, LT Marts, ON Obi, PHS Sporn, NJ Sweiss, S Shukla, N Kinnersley, G Walker, R BaughmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.